Chemoinformaics analysis of 2-METHOXY-3-METHYLPYRAZINE
| Molecular Weight | 124.143 | nRot | 1 |
| Heavy Atom Molecular Weight | 116.079 | nRig | 6 |
| Exact Molecular Weight | 124.064 | nRing | 1 |
| Solubility: LogS | 0.336 | nHRing | 1 |
| Solubility: LogP | 1.133 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 18.3563 |
| nHD | 0 | BPOL | 12.0417 |
| QED | 0.555 |
| Synth | 2.277 |
| Natural Product Likeliness | -0.919 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.366 |
| MDCK | 0.0000368 |
| BBB | 0.807 |
| PPB | 0.317832 |
| VDSS | 1.306 |
| FU | 0.66105 |
| CYP1A2-inh | 0.16 |
| CYP1A2-sub | 0.685 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.832 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.558 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.76 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.24 |
| CL | 8.385 |
| T12 | 0.604 |
| hERG | 0.017 |
| Ames | 0.292 |
| ROA | 0.414 |
| SkinSen | 0.916 |
| Carcinogencity | 0.408 |
| EI | 0.986 |
| Respiratory | 0.881 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.903293 |